PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2016.058201749110-19A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR–Tyrosine Kinase InhibitorsJi-Youn Han, Ki Hyeong Lee, Sang-We Kim, Young Joo Min, Eunkyung Cho, Youngjoo Lee, Soo-Hyun Lee, Hyae Young Kim, Geon Kook Lee, Byung Ho Nam, Hyesun Han, Jina Jung, Jin Soo Leehttp://e-crt.org/upload/pdf/crt-2016-058.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2016.058, http://www.e-crt.org/upload/pdf/crt-2016-058.pdf
Respirology10.1111/resp.13420_543201823286-286THE EGFR MUTATION PATTERN AFTER EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITORS THERAPY IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER HARBOURING ACTIVATING UNCOMMON EGFR MUTATIONShttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fresp.13420_543, http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13420_543/fullpdf
Cancer10.1002/cncr.287232014120152289-2298Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancerAdrian G. Sacher, Pasi A. Jänne, Geoffrey R. Oxnardhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.28723, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28723/fullpdf
Targeted Oncology10.1007/s11523-019-00659-z2019144491-491Correction to: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR‑Mutant Lung AdenocarcinomaChanghui Li, Bo Zhang, Jindong Guo, Fang Hu, Wei Nie, Xiaoxuan Zheng, Lixin Wang, Yuqing Lou, Yinchen Shen, Baohui Han, Xueyan Zhanghttp://link.springer.com/content/pdf/10.1007/s11523-019-00659-z.pdf, http://link.springer.com/article/10.1007/s11523-019-00659-z/fulltext.html, http://link.springer.com/content/pdf/10.1007/s11523-019-00659-z.pdf
Cancer Treatment Reviews10.1016/j.ctrv.2013.06.002201440193-101Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: A new era beginsJ. Remon, T. Morán, M. Majem, N. Reguart, E. Dalmau, D. Márquez-Medina, P. Lianeshttps://api.elsevier.com/content/article/PII:S0305737213001254?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737213001254?httpAccept=text/plain
Lung Cancer10.1016/j.lungcan.2013.01.0182013803235-241Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistanceErminia Massarelli, Faye M. Johnson, Heidi S. Erickson, Ignacio I. Wistuba, Vassiliki Papadimitrakopoulouhttps://api.elsevier.com/content/article/PII:S0169500213000548?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500213000548?httpAccept=text/plain
OncoTargets and Therapy10.2147/ott.s789112015783A case of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with MET amplification and epithelial-to-mesenchymal transitionSeigo Miyoshi, Takahide Kato, Hitoshi Katayama, Ryoji Ito, Takafumi Okura, Jitsuo Higaki, Yousuke Mizonihttps://www.dovepress.com/getfile.php?fileID=24550
10.21203/rs.3.rs-19425/v22020Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutationsYuichiro Takeda, Go Naka, Yoh Yamaguchi, Masao Hashimoto, Manabu Suzuki, Shinyu Izumi, Haruhito Sugiyamahttps://www.researchsquare.com/article/rs-19425/v2, https://www.researchsquare.com/article/rs-19425/v2.html
10.21203/rs.3.rs-19425/v32020Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutationsYuichiro Takeda, Go Naka, Yoh Yamaguchi, Masao Hashimoto, Manabu Suzuki, Shinyu Izumi, Haruhito Sugiyamahttps://www.researchsquare.com/article/rs-19425/v3, https://www.researchsquare.com/article/rs-19425/v3.html
10.21203/rs.3.rs-19425/v12020Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutationsYuichiro Takeda, Go Naka, Yoh Yamaguchi, Masao Hashimoto, Manabu Suzuki, Shinyu Izumi, Haruhito Sugiyamahttps://www.researchsquare.com/article/rs-19425/v1, https://www.researchsquare.com/article/rs-19425/v1.html